-
Alternative to EpiPen
-
PEMQBook Live Course Savings - Act Now!
-
Pfizer Joins Direct-to-Consumer Drug Sales
-
Updated Guidelines
-
Your Hard Work Pays Off
A Needle-less Alternative to EpiPen has FDA Approval. Will Doctors Prescribe It?
Neffy has twice the shelf life and is more durable under temperature extremes than EpiPens, but it’s being met with some skepticism. However, it’s not widely available on the market yet and doesn’t have an established history. Clinical trials show that the amount of epinephrine delivered to the bloodstream is the same as the EpiPen. It is supposed to be available in September.
A Needle-less Alternative to EpiPen has FDA Approval. Will Doctors Prescribe It?
Pfizer Joins Direct-to-Consumer Drug Sales
First Lilly, now Pfizer. Please note that we’re not just talking about drug companies filling prescriptions directly; we’re talking about drug companies writing prescriptions. The physician and pharmacy are being cut out of the loop. This is just nuts. Where are the physician organizations on this? The NP organizations?
This is kind of like having the insurance company own the hospital and pharmacy. Oh…wait…
Pfizer Joins Direct-to-Consumer Drug Sales
Complicated Intra-Abdominal Infections IDSA Update
The IDSA has released updated guidelines on complicated intra-abdominal infections (IAIs), covering risk assessment, diagnostic imaging, and microbiologic evaluation. Key recommendations include using the APACHE II scale for risk stratification, abdominal CT for adults with suspected appendicitis, and ultrasonography for pediatric patients. The guidelines emphasize the need for intra-abdominal cultures in immunocompromised patients and suggest limited routine cultures for others.
Complicated Intra-Abdominal Infections IDSA Update - Infectious Disease Advisor
 Save Money on our Medical Review Courses
To honor your hard work and contributions, enjoy 15% off CME, MOCs, Board Prep, and more! This limited-time offer is our way of saying thank you.
Save on EM, FM, IM, PEDS, OBGYN, NP, PA, State Requirements, and more!
|
